Ticker Details
Biogen Inc. Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
IPO Date:	January 3, 1994
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$32.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$2.66 | 1.46%
Avg Daily Range (30 D):	$4.03 | 1.98%
Avg Daily Range (90 D):	$3.51 | 1.77%

Institutional Daily Volume
Avg Daily Volume:	2.05M
Avg Daily Volume (30 D):	.89M
Avg Daily Volume (90 D):	.86M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	37
Avg Trade Size (Sh.) (90 D):	37

Institutional Trades
Total Institutional Trades:	45,141
Avg Institutional Trade:	$6.27M
Avg Institutional Trade (30 D):	$18.51M
Avg Institutional Trade (90 D):	$18.05M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	7

Market Closing Trades
Avg Closing Trade:	$28.83M
Avg Closing Trade (30 D):	$42.27M
Avg Closing Trade (90 D):	$46.63M
Avg Closing Volume:	141.04K

News

Aug 6, 2026 @ 10:15 PM Biogen Completes Acquisition of RayThera Inc. Source: Na

Aug 3, 2026 @ 10:05 PM Why Supernus Pharmaceuticals Stock Topped the Mark... Source: Eric Volkman

Jul 30, 2026 @ 1:09 PM VHT vs. PBE: Which Health Care ETF Is the Better B... Source: Andy Gould

Jul 29, 2026 @ 11:23 PM Why Biogen Stock Topped the Market Today Source: Eric Volkman

Jul 15, 2026 @ 3:00 PM Autoimmune Disease Therapeutics Market Size to Rea... Source: Sns Insider

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$5.68	$.66	$2.17
Diluted EPS	$5.63	$.66	$2.15
Revenue	$10.03B	$2.74B	$2.48B
Gross Profit	$7.42B	$1.96B	$1.82B
Net Income / Loss	$834.6M	$97.5M	$319.5M
Operating Income / Loss	$1.01B	$132.4M	$377.7M
Cost of Revenue	$2.61B	$776.9M	$661M
Net Cash Flow	$-1473.8M	$-2097.7M	$374.2M
PE Ratio

Splits
Jan 18, 2001	3:1